Akanda Corp. Strengthens with Strategic Sale
Company Announcements

Akanda Corp. Strengthens with Strategic Sale

Akanda Corp (AKAN) has released an update.

Akanda Corp. has successfully sold its Portuguese subsidiary RPK to Somai Pharmaceuticals Ltd. for $2 million, along with the assumption of approximately €4 million in debt. The transaction enhances Akanda’s financial stability and enables further focus on its UK subsidiary Canmart and the development of the Gabriola Green Project in Canada. This sale marks a strategic shift for Akanda, positioning it for anticipated growth in the global cannabis market.

For further insights into AKAN stock, check out TipRanks’ Stock Analysis page.

Related Articles
TipRanks Auto-Generated NewsdeskAkanda Corp. Announces Reverse Stock Split for Shareholders
TipRanks Auto-Generated NewsdeskAkanda Corp. Shows Financial Growth Amid Challenges
TipRanks Auto-Generated NewsdeskAkanda Corp. Announces Public Offering of Shares
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App